GC33061
Rociletinib hydrobromide
Also listed as Rociletinib hydrobromide (CO-1686 (hydrobromide))
Rociletinib hydrobromide (CO-1686 (hydrobromide)) (CO-1686 hydrobromide) is an orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M, and the Ki values for EGFRL858R/T790M and EGFRWT are 21·5 nM and 303·3 nM, respectively
ChemicalCAS1446700-26-0MW636.46FormulaC27H29BrF3N7O3
- CAS number
- 1446700-26-0
- Molecular weight
- 636.46
- Formula
- C27H29BrF3N7O3
- Solubility
- DMSO ： ≥ 59 mg/mL (92·70 mM)
- InChIKey
- IPKRDUJIGYXXNT-UHFFFAOYSA-N
- Catalogue number
- GC33061
- Brand
- GLPBIO
Computed properties PubChem CID 71725151 · TPSA 112 Ų · H-bond donors 4 · H-bond acceptors 11
- TPSA
- 112 Ų
- H-bond donors
- 4
- H-bond acceptors
- 11
- Rotatable bonds
- 8
- Heavy atoms
- 41
SMILES CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC.Br
Computed descriptors from PubChem (CID 71725151), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il